364 related articles for article (PubMed ID: 25951294)
1. N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: Synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia.
Salum LB; Mascarello A; Canevarolo RR; Altei WF; Laranjeira AB; Neuenfeldt PD; Stumpf TR; Chiaradia-Delatorre LD; Vollmer LL; Daghestani HN; de Souza Melo CP; Silveira AB; Leal PC; Frederico MJ; do Nascimento LF; Santos AR; Andricopulo AD; Day BW; Yunes RA; Vogt A; Yunes JA; Nunes RJ
Eur J Med Chem; 2015; 96():504-18. PubMed ID: 25951294
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
3. Development of Novel Bis(indolyl)-hydrazide-Hydrazone Derivatives as Potent Microtubule-Targeting Cytotoxic Agents against A549 Lung Cancer Cells.
Das Mukherjee D; Kumar NM; Tantak MP; Das A; Ganguli A; Datta S; Kumar D; Chakrabarti G
Biochemistry; 2016 May; 55(21):3020-35. PubMed ID: 27110637
[TBL] [Abstract][Full Text] [Related]
4. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
[TBL] [Abstract][Full Text] [Related]
5. Discovery of New Antiproliferative Imidazopyrazole Acylhydrazones Able To Interact with Microtubule Systems.
Brullo C; Rapetti F; Alfei S; Maric I; Rizzelli F; Mapelli M; Rosano C; Viale M; Bruno O
ChemMedChem; 2020 Jun; 15(11):961-969. PubMed ID: 32233110
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Series of Acridinones as Mechanism-Based Tubulin Assembly Inhibitors with Anticancer Activity.
Magalhaes LG; Marques FB; da Fonseca MB; Rogério KR; Graebin CS; Andricopulo AD
PLoS One; 2016; 11(8):e0160842. PubMed ID: 27508497
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of bis(indolyl)ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors.
Tantak MP; Klingler L; Arun V; Kumar A; Sadana R; Kumar D
Eur J Med Chem; 2017 Aug; 136():184-194. PubMed ID: 28494255
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel vinyl sulfone derivatives as anti-tumor agents with microtubule polymerization inhibitory and vascular disrupting activities.
Li W; Yin Y; Yao H; Shuai W; Sun H; Xu S; Liu J; Yao H; Zhu Z; Xu J
Eur J Med Chem; 2018 Sep; 157():1068-1080. PubMed ID: 30176537
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and SAR requirements of adamantane-colchicine conjugates with both microtubule depolymerizing and tubulin clustering activities.
Zefirova ON; Nurieva EV; Shishov DV; Baskin II; Fuchs F; Lemcke H; Schröder F; Weiss DG; Zefirov NS; Kuznetsov SA
Bioorg Med Chem; 2011 Sep; 19(18):5529-38. PubMed ID: 21873068
[TBL] [Abstract][Full Text] [Related]
10. Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays.
Kiselyov AS; Semenova MN; Chernyshova NB; Leitao A; Samet AV; Kislyi KA; Raihstat MM; Oprea T; Lemcke H; Lantow M; Weiss DG; Ikizalp NN; Kuznetsov SA; Semenov VV
Eur J Med Chem; 2010 May; 45(5):1683-97. PubMed ID: 20110137
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
Xu F; Li W; Shuai W; Yang L; Bi Y; Ma C; Yao H; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2019 Jul; 173():1-14. PubMed ID: 30981112
[TBL] [Abstract][Full Text] [Related]
13. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
[TBL] [Abstract][Full Text] [Related]
14. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
[TBL] [Abstract][Full Text] [Related]
15. 1H-benzimidazole-2-yl hydrazones as tubulin-targeting agents: Synthesis, structural characterization, anthelmintic activity and antiproliferative activity against MCF-7 breast carcinoma cells and molecular docking studies.
Anichina K; Argirova M; Tzoneva R; Uzunova V; Mavrova A; Vuchev D; Popova-Daskalova G; Fratev F; Guncheva M; Yancheva D
Chem Biol Interact; 2021 Aug; 345():109540. PubMed ID: 34139148
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors.
Mirzaei S; Eisvand F; Hadizadeh F; Mosaffa F; Ghasemi A; Ghodsi R
Bioorg Chem; 2020 May; 98():103711. PubMed ID: 32179282
[TBL] [Abstract][Full Text] [Related]
17. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY
J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of 1-substituted -2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents.
Li L; Quan D; Chen J; Ding J; Zhao J; Lv L; Chen J
Eur J Med Chem; 2019 Dec; 184():111732. PubMed ID: 31610372
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 2-alkoxy and 2-benzyloxy analogues of estradiol as anti-breast cancer agents through microtubule stabilization.
Sathish Kumar B; Kumar A; Singh J; Hasanain M; Singh A; Fatima K; Yadav DK; Shukla V; Luqman S; Khan F; Chanda D; Sarkar J; Konwar R; Dwivedi A; Negi AS
Eur J Med Chem; 2014 Oct; 86():740-51. PubMed ID: 25238172
[TBL] [Abstract][Full Text] [Related]
20. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH
Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
